In the present study, we found increased inflammation, lymphangiogenesis, M2-TAM, and CAFs in tumor tissues composed of cancer cells that originally promoted EMT induction, and CCL5 and IL-6 secreted by the inflammation further enhanced EMT induction in cancer cells. The gene discussed is IL6; the disease is cancer.